| UniProt ID | TMCO1_HUMAN | |
|---|---|---|
| UniProt AC | Q9UM00 | |
| Protein Name | Calcium load-activated calcium channel {ECO:0000305|PubMed:27212239} | |
| Gene Name | TMCO1 {ECO:0000312|HGNC:HGNC:18188} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 188 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . Golgi apparatus membrane Multi-pass membrane protein . The first transmembrane region is required for localization to the endoplasmic reticulum (PubMed:27212239). A publication reported |
|
| Protein Description | Calcium-selective channel required to prevent calcium stores from overfilling, thereby playing a key role in calcium homeostasis. [PubMed: 27212239 In response to endoplasmic reticulum overloading, assembles into a homotetramer, forming a functional calcium-selective channel, regulating the calcium content in endoplasmic reticulum store] | |
| Protein Sequence | MSTMFADTLLIVFISVCTALLAEGITWVLVYRTDKYKRLKAEVEKQSKKLEKKKETITESAGRQQKKKIERQEEKLKNNNRDLSMVRMKSMFAIGFCFTALMGMFNSIFDGRVVAKLPFTPLSYIQGLSHRNLLGDDTTDCSFIFLYILCTMSIRQNIQKILGLAPSRAATKQAGGFLGPPPPSGKFS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSTMFADTL ------CCCCHHHHH | 28.69 | 24043423 | |
| 3 | Phosphorylation | -----MSTMFADTLL -----CCCCHHHHHH | 18.27 | 24043423 | |
| 8 | Phosphorylation | MSTMFADTLLIVFIS CCCCHHHHHHHHHHH | 21.75 | 24043423 | |
| 15 | Phosphorylation | TLLIVFISVCTALLA HHHHHHHHHHHHHHH | 10.32 | 24043423 | |
| 18 | Phosphorylation | IVFISVCTALLAEGI HHHHHHHHHHHHCCC | 20.41 | 24043423 | |
| 26 | Phosphorylation | ALLAEGITWVLVYRT HHHHCCCCEEEEEEC | 22.00 | 24043423 | |
| 31 | Phosphorylation | GITWVLVYRTDKYKR CCCEEEEEECHHHHH | 12.02 | 24043423 | |
| 40 (in isoform 1) | Ubiquitination | - | 46.67 | 21890473 | |
| 40 (in isoform 2) | Ubiquitination | - | 46.67 | 21890473 | |
| 40 | Ubiquitination | TDKYKRLKAEVEKQS CHHHHHHHHHHHHHH | 46.67 | 21906983 | |
| 45 | Ubiquitination | RLKAEVEKQSKKLEK HHHHHHHHHHHHHHH | 66.11 | - | |
| 53 | Ubiquitination | QSKKLEKKKETITES HHHHHHHHHHHHHHH | 46.60 | - | |
| 54 | Ubiquitination | SKKLEKKKETITESA HHHHHHHHHHHHHHH | 71.77 | - | |
| 56 | Phosphorylation | KLEKKKETITESAGR HHHHHHHHHHHHHHH | 41.92 | 25262027 | |
| 58 | Phosphorylation | EKKKETITESAGRQQ HHHHHHHHHHHHHHH | 31.16 | 29255136 | |
| 60 | Phosphorylation | KKETITESAGRQQKK HHHHHHHHHHHHHHH | 27.63 | 23401153 | |
| 60 (in isoform 2) | Phosphorylation | - | 27.63 | 25849741 | |
| 91 | 2-Hydroxyisobutyrylation | SMVRMKSMFAIGFCF HHHHHHHHHHHHHHH | 1.88 | - | |
| 97 (in isoform 2) | Ubiquitination | - | 2.21 | 21890473 | |
| 105 | 2-Hydroxyisobutyrylation | FTALMGMFNSIFDGR HHHHHHHHHHHHCCC | 5.55 | - | |
| 109 | Phosphorylation | MGMFNSIFDGRVVAK HHHHHHHHCCCEEEE | 9.04 | 18691976 | |
| 111 | Phosphorylation | MFNSIFDGRVVAKLP HHHHHHCCCEEEECC | 17.34 | 19007248 | |
| 116 | Ubiquitination | FDGRVVAKLPFTPLS HCCCEEEECCCCCHH | 45.12 | 21890473 | |
| 116 (in isoform 1) | Ubiquitination | - | 45.12 | 21890473 | |
| 120 | Phosphorylation | VVAKLPFTPLSYIQG EEEECCCCCHHHHCC | 22.75 | - | |
| 141 (in isoform 2) | Ubiquitination | - | 3.17 | 21890473 | |
| 153 (in isoform 2) | Ubiquitination | - | 9.10 | 21890473 | |
| 160 | Ubiquitination | SIRQNIQKILGLAPS HHHHHHHHHHCCCCC | 35.78 | 21906983 | |
| 160 (in isoform 1) | Ubiquitination | - | 35.78 | 21890473 | |
| 167 (in isoform 2) | Ubiquitination | - | 29.01 | 21890473 | |
| 171 | Phosphorylation | LAPSRAATKQAGGFL CCCCCHHHHHCCCCC | 23.78 | - | |
| 172 (in isoform 1) | Ubiquitination | - | 33.16 | 21890473 | |
| 172 | Ubiquitination | APSRAATKQAGGFLG CCCCHHHHHCCCCCC | 33.16 | 2190698 | |
| 184 | Phosphorylation | FLGPPPPSGKFS--- CCCCCCCCCCCC--- | 61.46 | 30266825 | |
| 186 (in isoform 1) | Ubiquitination | - | 46.93 | 21890473 | |
| 186 | Ubiquitination | GPPPPSGKFS----- CCCCCCCCCC----- | 46.93 | 21890473 | |
| 188 | Phosphorylation | PPPSGKFS------- CCCCCCCC------- | 42.68 | 25463755 | |
| 235 | Phosphorylation | ------------------------------------------------------ ------------------------------------------------------ | 18691976 | ||
| 239 | Phosphorylation | ---------------------------------------------------------- ---------------------------------------------------------- | 18691976 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMCO1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMCO1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMCO1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AT5F1_HUMAN | ATP5F1 | physical | 26344197 | |
| CY1_HUMAN | CYC1 | physical | 26344197 | |
| DHB12_HUMAN | HSD17B12 | physical | 26344197 | |
| ODPB_HUMAN | PDHB | physical | 26344197 | |
| RAB1B_HUMAN | RAB1B | physical | 26344197 | |
| RPN1_HUMAN | RPN1 | physical | 26344197 | |
| QCR8_HUMAN | UQCRQ | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| 213980 | Craniofacial dysmorphism, skeletal anomalies and mental retardation syndrome (CFSMR) | |||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60 AND SER-188, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-184 AND SER-188,AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-188, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND MASSSPECTROMETRY. | |